9332729|t|Transforming growth factor-beta protects human hNT cells from degeneration induced by beta-amyloid peptide: involvement of the TGF-beta type II receptor.
9332729|a|Post-mitotic, human neurons (hNT cells) which have a phenotype similar to that of terminally differentiated neurons of the central nervous system were generated by treating the NT2/D1 human teratocarcinoma cell line with retinoic acid. Treatment of both hNT and NT2/D1 cells with 10(-5) M beta-amyloid peptide fragment 25-35 (A beta P) for 24 h resulted in a decrease in cell viability as determined by MTT incorporation and Trypan blue exclusion, and also induced an apoptotic morphology in hNT cells. Pre-treatment of cells for 24 h with 10 ng/ml TGF-beta 1 or 2 before addition of A beta P reduced the apoptotic morphology of hNT cells and increased cell viability in hNT cells, but not in NT2/D1 cells. Results of RT-PCR, immunohistochemistry and analysis of receptor cross-linking of [125I]TGF-beta 1 to the cell membrane, all showed that the TGF-beta type II receptor is expressed by hNT cells, but not NT2/D1 cells. These results suggest that TGF-beta can protect human, terminally differentiated, TGF-beta type II receptor-positive neurons from A beta P toxicity. We propose that the increased expression of TGF-beta in brains of patients with Alzheimer's disease may offer some degree of neuroprotection if neurons also express a functional TGF-beta type II receptor.
9332729	0	31	Transforming growth factor-beta	Gene	7040
9332729	41	46	human	Species	9606
9332729	47	50	hNT	CellLine	CVCL:7929
9332729	127	152	TGF-beta type II receptor	Gene	7048
9332729	168	173	human	Species	9606
9332729	183	186	hNT	CellLine	CVCL:7929
9332729	331	337	NT2/D1	CellLine	CVCL:3407
9332729	338	343	human	Species	9606
9332729	344	359	teratocarcinoma	Disease	MESH:D018243
9332729	375	388	retinoic acid	Chemical	MESH:D014212
9332729	408	411	hNT	CellLine	CVCL:7929
9332729	416	422	NT2/D1	CellLine	CVCL:3407
9332729	443	478	beta-amyloid peptide fragment 25-35	Chemical	-
9332729	480	488	A beta P	Gene	26
9332729	557	560	MTT	Chemical	MESH:C070243
9332729	579	590	Trypan blue	Chemical	MESH:D014343
9332729	646	649	hNT	CellLine	CVCL:7929
9332729	703	718	TGF-beta 1 or 2	Gene	7040;7042
9332729	738	746	A beta P	Gene	26
9332729	783	786	hNT	CellLine	CVCL:7929
9332729	825	828	hNT	CellLine	CVCL:7929
9332729	847	853	NT2/D1	CellLine	CVCL:3407
9332729	949	957	TGF-beta	Gene	7040
9332729	1002	1027	TGF-beta type II receptor	Gene	7048
9332729	1044	1047	hNT	CellLine	CVCL:7929
9332729	1063	1069	NT2/D1	CellLine	CVCL:3407
9332729	1104	1112	TGF-beta	Gene	7040
9332729	1125	1130	human	Species	9606
9332729	1159	1184	TGF-beta type II receptor	Gene	7048
9332729	1207	1215	A beta P	Gene	26
9332729	1216	1224	toxicity	Disease	MESH:D064420
9332729	1270	1278	TGF-beta	Gene	7040
9332729	1292	1300	patients	Species	9606
9332729	1306	1325	Alzheimer's disease	Disease	MESH:D000544
9332729	1404	1429	TGF-beta type II receptor	Gene	7048
9332729	Association	26	7040
9332729	Association	MESH:D000544	7040
9332729	Association	26	7048
9332729	Bind	7040	7048
9332729	Association	26	7042
9332729	Association	MESH:D000544	7048
9332729	Association	MESH:D064420	7048
9332729	Association	MESH:D064420	7040

